Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
NCT ID: NCT00930904
Last Updated: 2017-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1847 participants
OBSERVATIONAL
2009-06-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has or is intended to receive an Attain Ability Model 4196 LV lead
* Patient within 30 day post implant enrollment window
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
4196 LV Lead Chronic Performance Study Team
Role: STUDY_CHAIR
Medtronic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Anchorage, Alaska, United States
Gilbert, Arizona, United States
Phoenix, Arizona, United States
Scottsdale, Arizona, United States
Little Rock, Arkansas, United States
Bakersfield, California, United States
Chula Vista, California, United States
Downey, California, United States
East Palo Alto, California, United States
Long Beach, California, United States
Salinas, California, United States
San Bernardino, California, United States
Torrance, California, United States
Van Nuys, California, United States
Colorado Springs, Colorado, United States
Denver, Colorado, United States
Newark, Delaware, United States
Washington D.C., District of Columbia, United States
Bradenton, Florida, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
Melbourne, Florida, United States
Wellington, Florida, United States
Atlanta, Georgia, United States
Columbus, Georgia, United States
Marietta, Georgia, United States
Oak Lawn, Illinois, United States
Evansville, Indiana, United States
Indianapolis, Indiana, United States
Des Moines, Iowa, United States
Kansas City, Kansas, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Alexandria, Louisiana, United States
Baton Rouge, Louisiana, United States
Baltimore, Maryland, United States
Salisbury, Maryland, United States
Silver Spring, Maryland, United States
Takoma Park, Maryland, United States
Worcester, Massachusetts, United States
Grand Blanc, Michigan, United States
Marquette, Michigan, United States
Saginaw, Michigan, United States
Ypsilanti, Michigan, United States
Robbinsdale, Minnesota, United States
Rochester, Minnesota, United States
Columbia, Missouri, United States
Kansas City, Missouri, United States
Lebanon, New Hampshire, United States
Browns Mills, New Jersey, United States
Ocean City, New Jersey, United States
Parlin, New Jersey, United States
West Orange, New Jersey, United States
Albuquerque, New Mexico, United States
Huntington, New York, United States
Utica, New York, United States
Durham, North Carolina, United States
Greensboro, North Carolina, United States
Hickory, North Carolina, United States
Winston-Salem, North Carolina, United States
Fargo, North Dakota, United States
Akron, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Toledo, Ohio, United States
Portland, Oregon, United States
Erie, Pennsylvania, United States
Lancaster, Pennsylvania, United States
Sayre, Pennsylvania, United States
Charleston, South Carolina, United States
Columbia, South Carolina, United States
Florence, South Carolina, United States
Chattanooga, Tennessee, United States
Germantown, Tennessee, United States
Kingsport, Tennessee, United States
Nashville, Tennessee, United States
Amarillo, Texas, United States
Austin, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
San Antonio, Texas, United States
The Woodlands, Texas, United States
Burlington, Vermont, United States
Fairfax, Virginia, United States
Olympia, Washington, United States
Spokane, Washington, United States
Madison, Wisconsin, United States
Milwaukee, Wisconsin, United States
Linz, , Austria
Hasselt, , Belgium
Ottawa, Ontario, Canada
Ste-Foy, Quebec, Canada
Kingston, , Canada
Toronto, , Canada
Marseille, , France
Reggio Emilia, , Italy
Udine, , Italy
Eindhoven, , Netherlands
Rotterdam, , Netherlands
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4196 Chronic Performance
Identifier Type: -
Identifier Source: org_study_id